Title: Porous hollow fiber membrane-based continuous cross-flow anti-solvent crystallizer for production of API nanocrystals
In porous hollow fiber membrane (HFM) based anti-solvent crystallization (AsCr) technique, the anti-solvent is injected from HFM bore into the active pharmaceutical ingredient (API) containing solution flowing in the shell side. Conventionally, shell-side feed solution flows along the HFM. In our compact module design, the shell-side liquid flows perpendicular to the HFMs; the mean flow length is ~ 3 cm reducing considerably the residence time (tres) which strongly influences crystal growth. We investigated AsCr of griseofulvin (GF) from its acetone solution using anti-solvent water injected through HFM pores. The range of tres was 5–30 s; the volume flow rate ratio (FRR) of acetone/water ranged between 0.35 and 1.66; griseofulvin concentration was varied between saturation (3.73 g/100 g acetone) to 0.4 g GF in 100 g of solution having 50 wt% acetone in the total solution. Low tres yielded nanocrystals < 100 nm. The average API crystal size (Davg) remained around 230 nm in a three hour- long experiment. At a fixed mass FRR of 1.34 ±0.1, Davg increased linearly from 48 to 280 nm as tres increased from 5 to 28 s. For two HFM modules in series with the nanocrystal suspension from one module fed to the next module independently fed with anti-solvent water, GF crystallization yields as high as 98 % were achieved. AsCr of L-glutamic acid in water with anti-solvent acetone in the same device illustrated continuous nanocrystal production and similar behaviors vis-`a-vis variations of tres and FRR. The cross-flow HFM based continuous AsCr technique can continuously produce nanocrystals of APIs.  more » « less
Award ID(s):
2310866
PAR ID:
10670672
Author(s) / Creator(s):
; ; ; ; ; ;
Editor(s):
Bruggen, Bart V
Publisher / Repository:
Elsevier
Date Published:
Journal Name:
Separation and Purification Technology
Volume:
377
Issue:
P3
ISSN:
1383-5866
Page Range / eLocation ID:
134331
Subject(s) / Keyword(s):
Sponsoring Org:
National Science Foundation
More Like this
  1. Bruggen, Bart V (Ed.)
    In porous hollow fiber membrane (HFM) based anti-solvent crystallization (AsCr) technique, the anti-solvent is injected from HFM bore into the active pharmaceutical ingredient (API) containing solution flowing in the shell side. Conventionally, shell-side feed solution flows along the HFM. In our compact module design, the shell-side liquid flows perpendicular to the HFMs; the mean flow length is ~ 3 cm reducing considerably the residence time (tres) which strongly influences crystal growth. We investigated AsCr of griseofulvin (GF) from its acetone solution using anti-solvent water injected through HFM pores. The range of tres was 5–30 s; the volume flow rate ratio (FRR) of acetone/water ranged between 0.35 and 1.66; griseofulvin concentration was varied between saturation (3.73 g/100 g acetone) to 0.4 g GF in 100 g of solution having 50 wt% acetone in the total solution. Low tres yielded nanocrystals < 100 nm. The average API crystal size (Davg) remained around 230 nm in a three hour- long experiment. At a fixed mass FRR of 1.34 ±0.1, Davg increased linearly from 48 to 280 nm as tres increased from 5 to 28 s. For two HFM modules in series with the nanocrystal suspension from one module fed to the next module independently fed with anti-solvent water, GF crystallization yields as high as 98 % were achieved. AsCr of L-glutamic acid in water with anti-solvent acetone in the same device illustrated continuous nanocrystal production and similar behaviors vis-`a-vis variations of tres and FRR. The cross-flow HFM based continuous AsCr technique can continuously produce nanocrystals of APIs. 
    more » « less
  2. Background/Objectives: The co-formulation of active pharmaceutical ingredients (APIs) is a growing strategy in biopharmaceutical development, particularly when it comes to improving solubility and bioavailability. This study explores a co-precipitation method to prepare co-formulated crystals of griseofulvin (GF) and dexamethasone (DXM), utilizing nanostructured, functionalized polylactic glycolic acid (nfPLGA) as a solubility enhancer. Methods: An antisolvent precipitation technique was employed to incorporate nfPLGA at a 3% concentration into the co-formulated GF and DXM, referred to as DXM-GF-nfPLGA. The dissolution performance of this formulation was compared to that of the pure drugs and the co-precipitated DXM-GF without nfPLGA. Results: Several characterization techniques, including electron microscopy (SEM), RAMAN, FTIR, TGA, and XRD, were used to analyze the nfPLGA incorporation and the co-precipitated co-formulations. The inclusion of nfPLGA significantly enhanced the dissolution and initial dissolution rate of both GF and DXM in the DXM-GF-nfPLGA formulation, achieving a maximum dissolution of 100%, which was not attained by the pure drugs or the DXM-GF formulation. The incorporation of nfPLGA also reduced the amount of time taken to reach 50% (T50) and 80% (T80) dissolution. T50 values decreased from 52 and 82 min (for pure DXM and GF) to 23 min for DXM-GF-nfPLGA, and the T80 improved to 50 min for DXM-GF-nfPLGA, significantly outpacing the pure compounds. Furthermore, incorporating nfPLGA into the crystal structures greatly accelerated the dissolution rates, with initial rates reaching 650.92 µg/min for DXM-GF-nfPLGA compared to 540.60 µg/min for DXM-GF, while pure GF and DXM showed lower rates. Conclusions: This work demonstrates that nfPLGA incorporation enhances dissolution performance by forming water channels within the API crystal via hydrogen-bonding interactions. This innovative nfPLGA incorporation method holds promise for developing hydrophobic co-formulations with faster solubility and dissolution rates. 
    more » « less
  3. Abstract Two different types of monoclinic HfO 2 nanocrystals were employed in this work to study the effect of nanocrystal shape and crystallinity on the structural defects in the YBa2Cu3O7−δ (YBCO) matrix as it leads to an enhancement of pinning performances of solution-derived YBCO nanocomposite films. In this work the nanorod-like HfO 2 nanocrystals obtained from surfactant-controlled synthesis led to short intergrowths surrounding the particles, while spherical HfO 2 nanocrystals from the solvent-controlled synthesis led to the formation of long stacking faults in the YBCO matrix. It means that the small difference in crystallinity, lattice parameters, nanocrystal structures, core diameter of preformed nanocrystals in colloidal solutions have a strong influence on the formation of the structural defects around the particles in the YBCO matrix, leading to different pinning performances. 
    more » « less
  4. Cellulose nanocrystal (CNC)-reinforced composites are gaining commercial attention on account of their high strength and sustainable sourcing. Grafting polymers to the CNCs in these composites has the potential to improve their properties, but current solution-based synthesis methods limit their production at scale. Utilizing dynamic hindered urea chemistry, a new method for the melt-functionalization of cellulose nanocrystals has been developed. This method does not require toxic solvents during the grafting step and can achieve grafting densities competitive with state-of-the-art solution-based grafting methods. Using cotton-sourced, TEMPO-oxidized CNCs, multiple molecular weights of poly(ethylene glycol) (PEG) as well as dodecane, polycaprolactone, and poly(butyl acrylate) were grafted to the CNC surface. With PEG-grafted nanoparticles, grafting densities of 0.47 chains nm−2 and 0.10 chains nm−2 were achieved with 2000 and 10,000 g mol−1 polymer chains respectively, both of which represent significant improvements over previous reports for solution-based PEG grafting onto CNCs. 
    more » « less
  5. Colloidal semiconductor nanocrystals (NCs) have emerged as promising candidates for developing solutionprocessable optical gain media with potential applications in integrated photonic circuits and lasers. However, the deployment of NCs in these technologies has been hindered by the nonradiative Auger recombination of multiexciton states, which shortens the optical gain lifetime and reduces its spectral range. Here, we demonstrate that these limitations can be overcome by using giant colloidal quantum shells (g-QSs), comprising a quantum-confined CdSe shell grown over a large (∼14 nm) CdS bulk core. Such bulk-nanoscale architecture minimizes exciton− exciton interactions, leading to suppressed Auger recombination and one of the broadest gain bandwidths reported for colloidal nanomaterials, spanning energies both above and, remarkably, below the bandgap. Ultrafast transient absorption and photoluminescence measurements demonstrate that the high-energy portion of optical gain arises from states containing more than 15 excitons per particle, while the unusual sub-bandgap gain behavior results from an Auger-assisted radiative recombination, a mechanism that has traditionally been viewed as a loss pathway. Collectively, these results reveal a unique gain regime associated with bulk-nanocrystal hybrid systems, which offers a promising path toward solution-processable light sources. 
    more » « less